Cargando…
Combination therapy of cold atmospheric plasma (CAP) with temozolomide in the treatment of U87MG glioblastoma cells
Cold atmospheric plasma (CAP) technology, a relatively novel technique mainly investigated as a stand-alone cancer treatment method in vivo and in vitro, is being proposed for application in conjunction with chemotherapy. In this study, we explore whether CAP, an ionized gas produced in laboratory s...
Autores principales: | Gjika, Eda, Pal-Ghosh, Sonali, Kirschner, Megan E., Lin, Li, Sherman, Jonathan H., Stepp, Mary Ann, Keidar, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7536419/ https://www.ncbi.nlm.nih.gov/pubmed/33020527 http://dx.doi.org/10.1038/s41598-020-73457-7 |
Ejemplares similares
-
A Novel Micro Cold Atmospheric Plasma Device for Glioblastoma Both In Vitro and In Vivo
por: Chen, Zhitong, et al.
Publicado: (2017) -
Theranostic Potential of Adaptive Cold Atmospheric Plasma with Temozolomide to Checkmate Glioblastoma: An In Vitro Study
por: Soni, Vikas, et al.
Publicado: (2022) -
Ceramide Is Involved in Temozolomide Resistance in Human Glioblastoma U87MG Overexpressing EGFR
por: Bassi, Rosaria, et al.
Publicado: (2023) -
Propolis changes the anticancer activity of temozolomide in U87MG human glioblastoma cell line
por: Markiewicz-Żukowska, Renata, et al.
Publicado: (2013) -
In Vitro Radiosensitizing Effects of Temozolomide on U87MG Cell Lines of Human Glioblastoma Multiforme
por: Borhani, Samira, et al.
Publicado: (2017)